SAB Biotherapeutics, Inc.

Big Cypress Acquisition Corp, trading under the ticker BCYP, was a blank-check company that completed its initial public offering in 2020 with a focus on the healthcare and biopharmaceutical sector. The SPAC, sponsored by Big Cypress Holdings LLC, filed a Form 10-Q with the SEC on August 9, 2021, covering quarterly operations while a definitive business combination agreement with SAB Biotherapeutics, Inc. — a clinical-stage biopharmaceutical company developing human polyclonal antibodies using genetically engineered cattle — was pending. At the time of filing, the combined company was operating under the SAB Biotherapeutics name in anticipation of the transaction's close. Sign up at SpacDesk for complete filing history, deal timelines, and sponsor analytics on BCYP and hundreds of other SPACs.